Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
Does a Custom Electronic Health Record Alert System Improve Physician Compliance With National Quality Measures for Palliative Bone Metastasis Radiotherapy? This approach aims to reduce delays in data ...
MRI reports and biopsy pathology reports were extracted from a cohort of 1,360,866 patients with PCa in the VA Cancer Registry System or the VA Corporate Data Warehouse, with 155,570 patients having ...
Predicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostatectomy or radiation therapy. Yet, prostate cancer ...
Erectile Dysfunction Should Prompt Diabetes Screening Rates of adverse pathology varied from 24% for men with more than 2 positive biopsy cores to 45% in men reclassified by Gleason score. Prostate ...
The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...
President Biden's diagnosis with an aggressive prostate cancer, highlighted the importance of the Gleason scoring system in determining treatment. A high Gleason score indicates a greater risk of ...
BOSTON, Oct. 3 -- The Gleason score of 7 for localized prostate cancer may be a moving prognostic target, according to investigators here. By relying on the two most prevalent biopsy patterns, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results